Hepatosplenic volumes and portal pressure gradient identify one-year further decompensation risk post-transjugular intrahepatic portosystemic shunt
2025-11-13
(Press-News.org) Background and Aims
Further decompensation in cirrhosis is associated with increased mortality. However, reliable tools to predict further decompensation after transjugular intrahepatic portosystemic shunt (TIPS) are currently limited. This study aimed to investigate the incidence and risk factors of further decompensation within one year post-TIPS in patients with cirrhosis and to develop a predictive model for identifying high-risk individuals.
Methods
This retrospective cohort study enrolled 152 patients with cirrhosis undergoing TIPS for variceal bleeding and/or refractory ascites (January 2018–January 2024). Patients were stratified according to one-year decompensation outcomes. LASSO regression and multivariable logistic analysis were used to identify predictors, and a nomogram was constructed and internally validated using bootstrapping (1,000 replicates).
Results
Among the 152 patients (median age 57.5 years [IQR 50.0–66.0]; 58.6% male; 58.6% viral/alcohol-associated etiology), 65.8% (100/152) achieved clinical stability at one year post-TIPS, while 34.2% (52/152) developed further decompensation. LASSO regression identified right hepatic lobe volume, spleen volume, and portal pressure gradient (PPG) reduction as key predictors, all independently associated with further decompensation risk in multivariable analysis (OR [95% CI]: 0.683 [0.535–0.873], 1.435 [1.240–1.661], and 0.961 [0.927–0.996], respectively). The nomogram demonstrated superior discrimination compared with PPG reduction alone and benchmark prognostic scores (AUC 0.854 [0.792–0.915] vs. 0.619–0.652; ΔAUC +0.201–+0.235, p < 0.001) with 92.3% sensitivity. High-risk patients (score > 86) had a 10.7-fold higher risk of further decompensation than low-risk patients (60.0% vs. 5.6%; p < 0.0001).
Conclusions
In summary, 34.2% of decompensated patients with cirrhosis experience further decompensation post-TIPS, despite improved outcomes in most. Right hepatic lobe volume and post-shunt PPG reduction were identified as protective factors against one-year further decompensation, whereas spleen volume emerged as an independent risk factor. The nomogram model constructed based on these indicators demonstrated promising discriminative accuracy in stratifying patients with decompensated cirrhosis who are at high risk of post-TIPS further decompensation, serving as an evidence-based decision-support tool to guide therapeutic selection, risk quantification, and personalized management.
Full text
https://xiahepublishing.com/2310-8819/JCTH-2025-00199
The study was recently published in the Journal of Clinical and Translational Hepatology.
The Journal of Clinical and Translational Hepatology (JCTH) is owned by the Second Affiliated Hospital of Chongqing Medical University and published by XIA & HE Publishing Inc. JCTH publishes high quality, peer reviewed studies in the translational and clinical human health sciences of liver diseases. JCTH has established high standards for publication of original research, which are characterized by a study’s novelty, quality, and ethical conduct in the scientific process as well as in the communication of the research findings. Each issue includes articles by leading authorities on topics in hepatology that are germane to the most current challenges in the field. Special features include reports on the latest advances in drug development and technology that are relevant to liver diseases. Regular features of JCTH also include editorials, correspondences and invited commentaries on rapidly progressing areas in hepatology. All articles published by JCTH, both solicited and unsolicited, must pass our rigorous peer review process.
Follow us on X: @xiahepublishing
Follow us on LinkedIn: Xia & He Publishing Inc.
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-11-13
There’s no scientific evidence that the gut microbiome causes autism, a group of scientists argue in an opinion paper publishing November 13 in the Cell Press journal Neuron. They point to the fact that conclusions from past research that supported this hypothesis—including observational studies, mouse models of autism, and human clinical trials—are undermined by flawed assumptions, small sample sizes, and inappropriate statistical methods.
“Despite ...
2025-11-13
NEW YORK, NY (Nov. 13, 2025)--A study of a pig kidney that flourished for two months in a brain-dead recipient shows that a protocol developed by Columbia University immunologists can help prevent long-term rejection of a xenotransplant.
In the study, surgeons at New York University Langone Health transplanted a pig kidney and the same animal’s thymus gland into a 57-year-old man with glioblastoma who had been declared brain-dead at the hospital. The study ...
2025-11-13
Researchers have uncovered and then overcome an obstacle that has led to the failure of pioneering efforts in xenotransplantation, in which an animal kidney is transplanted into a human.
More than 800,000 Americans have late-stage kidney disease yet only 3% receive a transplant each year, according to the U.S. Centers for Disease Control and Prevention. To boost the supply of available organs, experts are exploring the use of genetically modified pig kidneys. The genetic changes are meant to keep the human ...
2025-11-13
Platelets are small, disc-shaped cell fragments in the blood that are essential to stop bleeding and to initiate blood clotting after injury. Platelet transfusions in patients with severe trauma or medical conditions, including bone marrow disease, leukemia, or sepsis, can be lifesaving. Despite being a standard clinical practice, platelet transfusions face issues related to the availability of blood donations from which platelets are isolated, the relatively short shelf life of purified platelets, and the risk of an immune response in patients receiving platelets from unmatched donors.
A potential solution to this has been proposed ...
2025-11-13
About The Study: The current analysis illustrates that drug promotion content is frequently posted by individual creators, lacks essential risk information, and bears the hallmarks of undisclosed marketing. These findings suggest that posts circumvented established advertising principles and potentially eroded the fair balance crucial for informed patient decision-making, consistent with prior literature on traditional direct-to-consumer advertising’s impact on prescribing.
Corresponding Author: To contact the corresponding author, Alex Kresovich, PhD, email kresovich-alex@norc.org.
To access the embargoed ...
2025-11-13
About The Study: In this study, higher ultraprocessed food intake was associated with increased risk of early-onset colorectal conventional adenomas. These data highlight the important role of ultraprocessed foods in early-onset colorectal tumorigenesis and support improving dietary quality as a strategy to mitigate the increasing burden of early-onset colorectal cancer.
Corresponding Author: To contact the corresponding author, Andrew T. Chan, MD, MPH, email achan@mgh.harvard.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaoncol.2025.4777)
Editor’s Note: Please see the ...
2025-11-13
Thoughtful electronic health record system design can nudge physicians toward evidence-based, less invasive treatments
Doctors offered two or more treatment alternatives were significantly more likely to choose a better option (62%) than those offered only one (44%)
‘We’re trying to make it easier for physicians to do the right thing’
CHICAGO --- Having more options is always better — until it’s not.
Doctors face this paradox daily when choosing treatment plans for patients, especially under the pressure of packed clinical schedules. Too few choices can limit care, but too many can lead to decision ...
2025-11-13
Colorectal cancer used to be associated with old age, but diagnoses have become increasingly common in adults aged 50 or younger particularly in high-income countries like the United States. The reason for this trend is unclear, but a new study led by Mass General Brigham researchers, as part of the Cancer Grand Challenges PROSPECT team, suggests an important link to ultra-processed foods that merits closer investigation. By analyzing the diets and endoscopy results from almost 30,000 women, the team ...
2025-11-13
Pinned between the stomach and spine, the pancreas supervises both digestion and blood sugar in the body. It’s also the site of an aggressive cancer called pancreatic ductal adenocarcinoma, or PDAC.
PDAC is the most common type of pancreatic cancer, the third-leading cause of cancer deaths in the U.S. It’s difficult to detect and recurs about 70% of the time after treatment. Only 13% of those diagnosed survive more than five years.
A team of surgeons, anesthesiologists and engineers at the University of ...
2025-11-13
Taking a page from market research tactics, UC San Francisco experts are studying whether artificial intelligence (AI) can improve diagnosis of a complex liver condition by using the clinical notes of multiple providers.
Their recent study, published in Gastro Hep Advances, focused on hepatorenal syndrome (HRS), a complex condition associated with liver disease that is often difficult to diagnose during hospitalization. The researchers sought to learn if large language models could analyze the clinical notes of multiple physicians and other providers to improve ...
LAST 30 PRESS RELEASES:
[Press-News.org] Hepatosplenic volumes and portal pressure gradient identify one-year further decompensation risk post-transjugular intrahepatic portosystemic shunt
